FindTrial
Sign In

A single-center, prospective, randomized controlled study of the analgesic effect of ropivacaine combined with dexamethasone in ultrasound-guided pericapsular nerve block of the hip on preoperative elderly patients with hip fractures

A single-center, prospective, randomized controlled study of the analgesic effect of ropivacaine combined with dexamethasone in ultrasound-guided pericapsular nerve block of the hip on preoperative elderly patients with hip fractures

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059486
Enrollment
Unknown
Registered
2022-05-02
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Group 1:0.3% Ropivacaine
Group 2:0.3% Ropivacaine combined with dexamethasone

Sponsors

The 960th Hospital of the PLA Joint Logistice Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 50; 2. ASA grades I, II and III.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung and brain complications; 2. Hepatic and renal insufficiency; 3. Abnormal coagulation function and other diseases; 4. Allergy to local anesthetics; 5. The patient is mentally abnormal; 6. The patient himself or his family members refuse.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale score;—

Secondary

MeasureTime frame
Complications of nerve block;The need for additional analgesics;Quality of sleep;The satisfaction of patients;—

Countries

China

Contacts

Public ContactWang Fei

The 960th Hospital of the PLA Joint Logistice Support Force

wf_king_001@163.com+86 15064006255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026